Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostate-Specific Antigen | 7 | 2011 | 2469 | 0.750 |
Why?
|
Prostatic Neoplasms | 8 | 2011 | 11118 | 0.520 |
Why?
|
Radiotherapy, Conformal | 3 | 2011 | 548 | 0.370 |
Why?
|
Goserelin | 1 | 2009 | 126 | 0.310 |
Why?
|
Salvage Therapy | 2 | 2011 | 1264 | 0.250 |
Why?
|
Carcinoma, Small Cell | 1 | 2007 | 420 | 0.240 |
Why?
|
Aphasia | 1 | 2024 | 192 | 0.210 |
Why?
|
Androgen Antagonists | 1 | 2011 | 1410 | 0.200 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1520 | 0.180 |
Why?
|
Brachytherapy | 1 | 2008 | 1223 | 0.170 |
Why?
|
Disease-Free Survival | 4 | 2011 | 6814 | 0.150 |
Why?
|
Thoracic Wall | 1 | 2019 | 202 | 0.150 |
Why?
|
Mastectomy | 1 | 2024 | 1822 | 0.130 |
Why?
|
Anemia | 1 | 2024 | 1508 | 0.120 |
Why?
|
Pleural Neoplasms | 1 | 2019 | 609 | 0.120 |
Why?
|
Parkinson Disease | 1 | 2009 | 2877 | 0.120 |
Why?
|
Cryosurgery | 1 | 2019 | 474 | 0.120 |
Why?
|
Vitiligo | 1 | 2015 | 97 | 0.120 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 2892 | 0.110 |
Why?
|
Breast | 2 | 2024 | 1966 | 0.110 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2011 | 801 | 0.110 |
Why?
|
Skin Pigmentation | 1 | 2015 | 277 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3244 | 0.110 |
Why?
|
Combined Modality Therapy | 4 | 2008 | 8529 | 0.100 |
Why?
|
Treatment Failure | 2 | 2008 | 2642 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21012 | 0.100 |
Why?
|
Radiation Tolerance | 2 | 2004 | 479 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2024 | 64651 | 0.080 |
Why?
|
Lymphoma | 1 | 2018 | 1901 | 0.080 |
Why?
|
Radiation Protection | 1 | 2011 | 424 | 0.070 |
Why?
|
Survival Analysis | 4 | 2008 | 10089 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2019 | 80582 | 0.070 |
Why?
|
Aged | 13 | 2024 | 169235 | 0.070 |
Why?
|
Male | 15 | 2019 | 360736 | 0.060 |
Why?
|
Middle Aged | 13 | 2024 | 220826 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2008 | 646 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2008 | 11106 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3600 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5071 | 0.060 |
Why?
|
Deoxycytidine | 1 | 2008 | 877 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2011 | 1958 | 0.050 |
Why?
|
Prostatectomy | 1 | 2011 | 1824 | 0.050 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2011 | 1661 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2851 | 0.050 |
Why?
|
Tumor Burden | 1 | 2008 | 1890 | 0.050 |
Why?
|
Humans | 20 | 2024 | 761423 | 0.050 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2024 | 262 | 0.050 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2008 | 782 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2008 | 2898 | 0.050 |
Why?
|
Breast Implants | 1 | 2024 | 411 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2010 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6231 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20556 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2024 | 1784 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2651 | 0.040 |
Why?
|
Genes, ras | 1 | 2000 | 654 | 0.040 |
Why?
|
Survivors | 1 | 2008 | 2371 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2004 | 6132 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1998 | 350 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12456 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2008 | 3466 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2008 | 2223 | 0.030 |
Why?
|
Risk | 1 | 2008 | 9612 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12058 | 0.030 |
Why?
|
Mammaplasty | 1 | 2024 | 1239 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2011 | 13337 | 0.030 |
Why?
|
Female | 9 | 2024 | 392581 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2871 | 0.030 |
Why?
|
Time Factors | 2 | 2019 | 39975 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2018 | 953 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6766 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6485 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15262 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 5302 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2914 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3550 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12970 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36423 | 0.020 |
Why?
|
Neoplasms | 2 | 2015 | 22164 | 0.020 |
Why?
|
Adult | 4 | 2024 | 221148 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6479 | 0.020 |
Why?
|
Apoptosis | 2 | 2000 | 9488 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58956 | 0.020 |
Why?
|
Cystectomy | 1 | 2008 | 634 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12720 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3804 | 0.010 |
Why?
|
Genes, erbB-2 | 1 | 2004 | 162 | 0.010 |
Why?
|
Genes, erbB-1 | 1 | 2004 | 162 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13361 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4852 | 0.010 |
Why?
|
Cell Survival | 2 | 2000 | 5790 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9277 | 0.010 |
Why?
|
Fibrosarcoma | 1 | 2000 | 309 | 0.010 |
Why?
|
X-Rays | 1 | 1998 | 307 | 0.010 |
Why?
|
Clone Cells | 1 | 2000 | 1659 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2004 | 2455 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4466 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4510 | 0.010 |
Why?
|
Alleles | 1 | 2000 | 6922 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2000 | 8545 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2000 | 6339 | 0.000 |
Why?
|
Colorectal Neoplasms | 1 | 2000 | 6935 | 0.000 |
Why?
|
Animals | 1 | 1998 | 168441 | 0.000 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_